Objectives: Interstitial lung disease (ILD) is a debilitating and life-limiting condition, requiring
multi-disciplinary care. While guidelines recommend early specialist palliative care referral …

Abstract Background and Objective Interstitial lung disease (ILD) is progressive with high
symptom burdens and poor prognosis. Patients with ILD need optimal palliative care to …

Further research into the role of opioids, oxygen and neuromodulatory agents in symptom
management are needed. In addition, exploration of breathlessness and case conference …

Background Current guidelines recommend palliative care based on individual needs for
patients with idiopathic pulmonary fibrosis. However, patients with interstitial lung disease …

Introduction Patients with progressive idiopathic fibrotic interstitial lung disease (ILD), such
as those with idiopathic pulmonary fibrosis (IPF), can have an aggressive disease course …

Background: The morbidity and mortality of interstitial lung disease (ILD) is high, despite
novel therapeutics. Recognizing unmet needs for symptom management, advance care …

Background: Interstitial lung diseases (ILDs) comprise a heterogeneous group of fibrotic,
progressive pulmonary diseases characterized by poor end-of-life care and hospital deaths …

Objectives The importance of palliative care in those with advanced fibrotic interstitial lung
diseases (F-ILD) is recognised, but the palliative care requirements of patients and …

Background This study aimed to assess the palliative care needs of progressive idiopathic
fibrotic interstitial lung disease (PIF-ILD) populations in two London ILD centres. Methods …

Background: People dying from interstitial lung disease experience considerable symptoms
and commonly die in an acute healthcare environment. However, there is limited …